Skip to main navigation Skip to search Skip to main content

No association between CYP3A4*22 and statin effectiveness in reducing the risk for myocardial infarction.

  • M. Leusink
  • , C.E. de Keyser
  • , N.C. Onland-Moret
  • , A. Hofman
  • , L.E. Visser
  • , B.H.Ch Stricker
  • , P.I.W. de Bakker
  • , A. Boer
  • , R.H. van Schaik
  • , A.H. Maitland-van der Zee

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)1471-1477
Number of pages7
JournalPharmacogenomics
Volume15
Issue number11
DOIs
Publication statusPublished - 2014

Keywords

  • Econometric and Statistical Methods: General
  • Geneeskunde(GENK)
  • Medical sciences
  • Bescherming en bevordering van de menselijke gezondheid

Cite this